Overview
- Essilor’s Stellest lenses are authorized in the U.S. to slow, not just correct, childhood nearsightedness by using concentric rings of tiny raised dots to create peripheral defocus.
- In company-reported studies, children wearing Stellest showed about a 71% slower change in prescription and roughly a 53% reduction in eye elongation over two years versus controls.
- The FDA reported no serious adverse events during review, though some users experienced visual symptoms such as blur and halos.
- The suggested retail price is about $450, with insurance coverage still being determined, though some reports say major vision plans may cover eligible children.
- The glasses offer a non-contact option alongside MiSight contact lenses, which are approved for ages 8–12, as U.S. retailers expand availability of Stellest for ages 6–12.